MIRA INFORM REPORT

 

 

Report Date :

22.03.2013

 

IDENTIFICATION DETAILS

 

Name :

SYNERGY DIAGNOSTICS PRIVATE LIMITED

 

 

Registered Office :

127-128, Laxmi Market, 1st Floor, Vartak Nagar, Thane-400606, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

19.10.2000

 

 

Com. Reg. No.:

11-129252

 

 

Capital Investment / Paid-up Capital :

Rs. 10.000 Millions

 

 

CIN No.:

[Company Identification No.]

U85195MH2000PTC129252

 

 

IEC No.:

0300048106

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PNES09252A

 

 

PAN No.:

[Permanent Account No.]

AAECS9451N

 

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader, Exporter and Importer of Life Saving Drugs and Medicines.

 

 

No. of Employees :

175 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 580000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record. There appears some dip in the profitability of the company during current year. However, net worth appears to be satisfactory general financial position of the company is good. Trade relations are reported as fair. Business is active. Payments are reported to be correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Mukesh

Designation :

Accounts Department

Contact No.:

91-22-41424040

Date :

21.03.2013

 

 

LOCATIONS

 

Registered Office / Admin Office :

127-128, Laxmi Market, Vartak Nagar, Thane (West)-400606, Maharashtra, India 

Tel. No.:

91-22-41424040-69 (29 lines)/ 25888153/ 25888144

Fax No.:

91-22-25855120 / 41424070

E-Mail :

contact@synergydiagnostics.in

synergy.diagnostics@vsnl.net

Website :

www.synergydiagnostics.in

Area :

1600 sq ft

Location :

Owned

 

 

Warehouse :

1/ 2/ 3/ 4, Adarsh Apartment, Sector 20/C, Airoli, Navi Mumbai, Maharashtra, India

Tel. No.:

91-22-65114172

Area :

1000 sq ft

Location :

Owned

 

 

DIRECTORS

 

As on 28.09.2012

 

Name :

Mr. Sanjay Prabhakar Bawsay

Designation :

Director

Address :

AL/6/3/14, Ashiana Apartments, Sector-5, Airoli, Navi Mumbai-400708, Maharashtra, India

Date of Birth/Age :

25.10.1957

Qualification :

B.A. with DBM

Date of Appointment :

19.10.2000

DIN No.:

00321876

 

 

Name :

Mrs. Madhavi Sanjay Bawsay

Designation :

Chairman cum Managing Director

Address :

AL/6/3/14, Ashiana Apartments, Sector-5, Airoli, Navi Mumbai-400708, Maharashtra, India

Date of Birth/Age :

09.12.1958

Qualification :

Diploma in Nursing

Date of Appointment :

29.01.2001

DIN No.:

00526269

 

 

KEY EXECUTIVES

 

Name :

Mr. Mukesh

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 28.09.2012

 

Names of Shareholders

No. of Shares

Sanjay Prabhakar Bawsay

68500

Madhavi Sanjay Bawsay

31500

Total

100000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 28.09.2012

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader, Exporter and Importer of Life Saving Drugs and Medicines.

 

 

Exports :

 

Products :

Finished goods

Countries :

Srilanka

 

 

Imports :

 

Products :

Raw Material

Countries :

  • Israel
  • China
  • Aurtria

 

 

Terms :

 

Selling :

Cash and Credit (60 days)

 

 

Purchasing :

Cash and Credit (60 days)

 

 

GENERAL INFORMATION

 

Suppliers :

  • Human Bioplazma, Hungry
  • Kamada Limited, Israel
  • Ked Pharmaceuticals AG
  • Vaccine International Pte. Limited
  • Saveshwari Infocom Private Limited

 

 

Customers :

Hospitals Medical Institution and End users

 

  • Shah International
  • Sumukha Pharmaceuticals
  • Shree Marketing Pharma Distributors
  • Shah International
  • Ganesh Pharmaceuticals
  • Amrita Enterprises Private Limited
  • R P Enterprises
  • MP Quality Drug House
  • MP Vaccine House
  • Alpha Pharma
  • A G Enterprises
  • Pankaj Distributors
  • Zeus Distributors
  • Lotus Pharma Distributors
  • Medihauxe International

 

 

No. of Employees :

175 (Approximately)

 

 

Bankers :

  • Bank of India, Vandana House Near Vandana Cinema, L B S Marg, Thane - 400602, Maharashtra, India
  • Kotak Mahindra Bank
  • Centurian Bank of Punjab
  • ICICI Bank

 

 

Facilities :

Secured Loan

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

Loan from Kotak Mahindra Bank for Innova Car

0.000

0.028

Loan from BOI for TATA 207

(Secured against hypothecation of Vehicles and personal guarantees of Directors)

0.000

0.149

Bank of India-Cash Credit-36

111.428

65.172

Bank of India-Cash Credit-37

(Secured against hypothecation of Stock and Debtors and personal guarantees of Directors)

9.637

10.122

Loan from Kotak.Mahindra Bank for Innova Car

0.028

0.310

Loan from BOI for TATA 207

(Secured against hypothecation of Vehicles & personal guarantees of Directors)

0.150

0.124

Buyers Credit

0.000

41.377

BOI Working Capital Demand Loan - 002

(Secured against hypothecation of Stock and Debtors and  personal guarantees of Directors)

0.000

29.883

Total

121.243

147.165

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Shyam Shankar Mhaskar

Chartered Accountant

Address :

31, 2nd Floor, Laxmi Niwas Co-operative Housing Society, Ghantali Road, Naupada, Thane-400602, Maharashtra, India

Tel. No.:

91-22-25376574

Mobile No.:

91-9833200084

PAN No.:

AAWPM9348P

 

 

Subsidiary :

Vacc-Syn Biotech Private Limited

U24230MH2007PTC172190

Address: Badlapur, Mumbai, Maharashtra, India

Line of Business: Manufacturer of Life Saving Drugs and Medicines.

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.100/- each

Rs. 10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.100/- each

Rs. 10.000 Millions

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

10.000

10.000

1.425

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

134.276

101.665

67.261

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

144.276

111.665

68.686

LOAN FUNDS

 

 

 

1] Secured Loans

121.243

147.165

69.927

2] Unsecured Loans

23.758

0.000

1.377

TOTAL BORROWING

145.001

147.165

71.304

DEFERRED TAX LIABILITIES

0.307

0.310

0.288

 

 

 

 

TOTAL

289.584

259.140

140.278

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

51.227

52.247

12.486

Capital work-in-progress

0.000

1.069

0.000

 

 

 

 

INVESTMENT

18.500

10.100

5.875

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

111.370
212.696
68.195

 

Sundry Debtors

112.440
45.827
60.669

 

Cash & Bank Balances

0.361
7.125
15.820

 

Other Current Assets

73.978
90.826
0.000

 

Loans & Advances

78.387
40.226
84.614

Total Current Assets

376.536
396.700

229.298

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

124.682
141.151
52.677

 

Other Current Liabilities

2.425
1.817
4.605

 

Provisions

29.572
58.008
50.105

Total Current Liabilities

156.679
200.976

107.387

Net Current Assets

219.857
195.724
121.911

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.006

 

 

 

 

TOTAL

289.584

259.140

140.278

 

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

529.900

515.600

410.200

 

 

Other Income

NA

NA

 

 

 

TOTAL                                     (A)

NA

NA

410.200

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

NA

NA

NA

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

NA

NA

NA

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

NA

NA

72.359

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

NA

NA

2.518

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

52.021

72.158

69.841

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

1.165

1.330

1.379

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

50.856

62.056

68.462

 

 

 

 

 

Less

TAX                                                                  (H)

17.000

20.522

25.132

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

33.856

41.534

43.330

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

NA

298.536

 

TOTAL IMPORTS

NA

NA

298.536

 

 

 

 

 

 

Earnings Per Share (Rs.)

338.57

415.34

3040.71

 

Expected Sales (2012-2013): Rs. 520.000 Millions

 

The above information has been parted by Mr. Mukesh (Accounts Department)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

NA

NA

10.56

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

9.60

12.04

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

11.89

13.82

28.32

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.35

0.56

1.00

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.01

1.32

1.04

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.40

1.97

2.14

 

 

LOCAL AGENCY FURTHER INFORMATION

 

SUNDRY CREDITORS DETAILS:

 

Particulars

31.03.2012

31.03.2011

31.03.2010

 

(Rs. In Millions)

Human Bioplazma, Hungry-Direct

38.001

26.327

52.677

Kamada Limited, Israel-Direct

24.924

10.621

 

Ked Pharmaceuticals AG

40.519

98.957

 

Vaccine International Pte. Limited

21.214

5.247

 

Saveshwari Infocom Private Limited

0.024

0.000

 

Total

124.682

141.152

52.677

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

NOTE

 

The registered office of the company has been shifted from AL-6/3/14/Ashiana Apartment, Sector 5, Airoli, Navi Mumbai-400708, Maharashtra, India  to the present address w.e.f. 28.07.2009

 

 

UNSECURED LOAN

 

Unsecured Loan

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. In Millions)

S E Investment

 

4.049

0.000

Loan from Dhanlaxmi Bank

2.018

0.000

Karma Booking Private Limited

8.450

0.000

S E Investment

8.400

0.000

Loan from Dhanlaxmi Bank

0.841

0.000

Total

 23.758

0.000

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U85195MH2000PTC129252

Name of the company

SYNERGY DIAGNOSTICS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

127-128, Laxmi Market, 1st Floor, Vartak Nagar, Thane-400606, Maharashtra, India

Email: synergy.diagnostics@vsnl.net

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10198244

Type of charge

  • Book debts
  • Movable property (not being pledge)

Particular of charge holder

Bank of India, Vandana House Near Vandana Cinema, L B S Marg, Thane - 400602, Maharashtra, India

Email: Panchpakhadi.RaigadThane@bankofindia.co.in

Nature of instrument creating charge

Supplemental Deed Of Hypothecation Dated 9.5.2012 (6th)

Date of instrument Creating the charge

09.05.2012

Amount secured by the charge

Rs.230.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

1. FOR WCFBL@3.5% over base rate presently 14% p.a. With monthly rest

2. For NFBL: Commission As Applicable

 

Terms of Repayment

Repayable with interest @ 3.5% over br presently 14% p.a. With monthly rest

 

Margin

1. Cash credit-25% against stock

                            -40% against book debts

2. Inland/Foreign L/C-20% TDR

3. Inland Bank Guarantee-20% TDR

 

Extent and Operation of the charge

Original hyp chrge of 80.000 millions dt. 17.12.09 increased to 105.000 millions on 20.08.10 increased to 125.000 millions on 27.08.10 reduced to 100.000 millions and increased to 150.000 millions on 18.12.10 increased to 195.000 millions on 08.03.11 reduced to 180.000 millions on 09.06.11 modified terms on 25.10.11 now increased to 230.000 millions.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

All tangible movable machineries installed in borrowers premises godown at gala no 127 to 129 Laxmi Market Vartak Nagar Thane And Shop No 1 to 4 Plot No 8-81 Sector 20 Airoli Navi Mumbai

 

All tangible movable properties assets and stocks of raw material situated at gala no 127 to 129 laxmi market vartak nagar thane and Shop No 1 to 4 Plot No 8-81 sector 20 Airoli Navi Mumbai

 

All present and future book debts outstandings

Date of instrument modifying the charge

25.10.2011

Particulars of the present modification

Original hypothecation charge of 80.000 millions increased to 105.000 millions further increased to 125.000 millions reduced to 100.000 millions then increased to 150.000 millions further increased to 195.000 millions reduced to 180.000 millions which remained to 180.000 millions on modified terms on 25/10/11 now increased to 230.000 millions comprising of WCFBL 140.000 millions and NFBL 90.000 millions.

 

 

FIXED ASSETS

 

  • Land at Badalapur
  • Industrial Building
  • Land Ambernath
  • Office Premises
  • Godown
  • Office Equipments
  • Plant and Machinery
  • Furniture and Fixture
  • Vehicles
  • Computers

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.28

UK Pound

1

Rs.82.06

Euro

1

Rs.72.23

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.